— Know what they know.
Not Investment Advice
Also trades as: BMK.L (LSE) · $vol 0M

BHCCF OTC

Benchmark Holdings plc
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +36579900.0% 1Y: +0.0% 3Y: -53.7% 5Y: -53.7%
$0.37
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 51 · $225.1M mcap · 434M float · 0.0003% daily turnover · Short 100% of daily vol

Income Trends

Revenue
$90M -46.7% ▼
5Y CAGR: -6.6%
Gross Profit
$44M -49.3% ▼
5Y CAGR: -7.8%
Operating Income
-$35M -567.8% ▼
Net Income
-$39M -70.5% ▼
EPS (Diluted)
$-0.05 -121.6% ▼
EBITDA
$11M +1.6% ▲
5Y CAGR: -18.7%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$106M$125M$158M$169M$90M
YoY Growth-17.1%+18.5%+26.6%+7.1%-46.7%
Cost of Revenue$51M$59M$75M$83M$46M
Gross Profit$55M$66M$84M$87M$44M
Gross Margin52.1%52.4%53.0%51.2%48.6%
R&D Expenses$7M$8M$9M$6M$2M
SG&A Expenses$33M$38M$44M$0$0
Operating Expenses$64M$71M$90M$92M$79M
Operating Income-$11M-$5M-$6M-$5M-$35M
Operating Margin-10.3%-4.3%-3.9%-3.1%-39.3%
Interest Expense$8M$8M$11M$11M$8M
Income Before Tax-$23M-$9M-$21M-$13M-$46M
Tax Expense$204K$2M$7M$3M-$2M
Net Income-$33M-$13M-$32M-$23M-$39M
Net Margin-31.2%-10.3%-20.3%-13.7%-43.7%
EPS (Diluted)$-0.05$-0.02$-0.05$-0.02$-0.05
EBITDA$14M$23M$21M$11M$11M
Shares Outstanding625M669M698M732M740M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms